Mrinal Gounder

Associate Professor of Medicine
Medicine

Mrinal Gounder serves as Associate Professor at Cornell University.

600 publications
21,412 citations
52 h-index
Medicine
Rising Papers (1)
2025-01-06 · Nature Communications · Molecular Biology
MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial
Mrinal M. GounderAssociate Professor of Medicine · Medicine
44 citations · 15.0x expected for field
Top Papers (1)
2019-01-08 · Nature Genetics · Oncology
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Mrinal M. GounderAssociate Professor of Medicine · Medicine
226.8x expected for field · 4,455 citations
Recent Papers (16)
2026-09-01 · European Journal of Cancer · Rheumatology
Natural History and Treatment Outcomes in Aggressive Angiomyxoma: A Single Institution Experience
Mrinal M. GounderAssociate Professor of Medicine · Medicine
2026-08-14 · Clinical Cancer Research · Oncology
BRIGHTLINE-1: When a Negative Trial Reveals Two Active Therapies
Mrinal M. GounderAssociate Professor of Medicine · Medicine
2026-06-01 · Cancer Medicine · Oncology
Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials
Mrinal M. GounderAssociate Professor of Medicine · Medicine
Sandra P. D'AngeloAssociate Professor of Medicine · Medicine
2026-05-28 · Journal of Clinical Oncology · Gastroenterology
Phase 1a/1b study of the safety, pharmacokinetics, and antitumor activity of ziftomenib in combination with imatinib in patients with advanced gastrointestinal stromal tumors (GIST) after imatinib failure.
Mrinal M. GounderAssociate Professor of Medicine · Medicine
2026-05-01 · Journal for ImmunoTherapy of Cancer · Pulmonary and Respiratory Medicine
Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma
Mrinal M. GounderAssociate Professor of Medicine · Medicine
Sandra D'AngeloAssociate Professor of Medicine · Medicine
2026-03-25 · Nature Communications · Molecular Biology
Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study
Mrinal M. GounderAssociate Professor of Medicine · Medicine
2026-03-01 · ESMO rare cancers. · Rheumatology
203P Efficacy of nirogacestat in improving sleep outcomes in adults with desmoid tumors: Post hoc analysis from the DeFi trial
2026-03-01 · ESMO rare cancers. · Rheumatology
124P Efficacy of nirogacestat in improving emotional impact outcomes in adults with desmoid tumors: Post hoc analysis from the DeFi Trial
2026-02-26 · JCO oncology advances. · Pulmonary and Respiratory Medicine
Systemic Therapy Outcomes for Soft Tissue Leiomyosarcoma Patients in an Era of Next-Generation Sequencing
Mrinal M. GounderAssociate Professor of Medicine · Medicine
2026-02-12 · Clinical Cancer Research · Oncology
Association of Circulating T Cell and Tumor Microenvironment Profiles with Immune Checkpoint Blockade Outcomes in Sarcoma
Mrinal M. GounderAssociate Professor of Medicine · Medicine
2025-12-01 · Cancer Research Communications · Pulmonary and Respiratory Medicine
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma
Mrinal M. GounderAssociate Professor of Medicine · Medicine
2025-12-01 · ESMO rare cancers.
IMPACT OF PRIOR SYSTEMIC THERAPY ON TAZEMETOSTAT EFFICACY IN ADVANCED EPITHELIOID SARCOMA: POST HOC ANALYSIS OF STUDY EZH-202
Mrinal M. GounderAssociate Professor of Medicine · Medicine
2025-12-01 · ESMO rare cancers.
ASSOCIATION OF CLINICO-PATHOLOGIC FEATURES AND MOLECULAR GENOTYPES WITH OUTCOMES OF SYSTEMIC THERAPY IN METASTATIC SOFT TISSUE LEIOMYOSARCOMA (LMS) PATIENTS
Mrinal M. GounderAssociate Professor of Medicine · Medicine
2025-12-01 · ESMO rare cancers.
SAFETY AND EARLY EFFICACY OF VT3989, A TEAD INHIBITOR, IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA (EHE): A PHASE I/II STUDY
Mrinal M. GounderAssociate Professor of Medicine · Medicine
2025-10-20 · Journal of Clinical Oncology · Rheumatology
Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial
Mrinal M. GounderAssociate Professor of Medicine · Medicine
2025-09-29 · Journal of Onco-Nephrology · Rheumatology
Gamma-secretase inhibitor-associated hypophosphatemia in patients with desmoid tumor
Mrinal M. GounderAssociate Professor of Medicine · Medicine